• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Outro Secures $7M to Build Healthcare’s First Neuroscience-Based Deprescribing Platform

by Jasmine Pennic 10/12/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know

  • Neuroscience-based deprescribing platform Outro announced that it has raised $7M in combined pre-seed and seed financing to establish clinical and technological infrastructure for discontinuing psychiatric medications safely.
  • The financing syndicate is backed by Listen Ventures, Cake Ventures, Jason Calacanis’s LAUNCH, Actions Capital, Hannah Grey VC, SemperVirens, Brock Recovery Group, Pave Health Ventures, and additional strategic digital health investors.
  • Outro combines specially trained deprescribing clinicians, evidence-informed hyperbolic tapering protocols, continuous remote patient monitoring, longitudinal psychosocial counseling, and purpose-built software.

Clinical Architecture: Grounding Tapering in Neurobiology

Founded by digital health entrepreneur Brandon Goode and clinical researcher Dr. Mark Horowitz, Outro translates specialized psychopharmacology into an outpatient virtual delivery model:

  • Scientific Foundation: Co-founder Dr. Mark Horowitz is a leading global researcher on psychiatric medication discontinuation whose academic work established the neurobiological basis for hyperbolic tapering—a protocol that reduces drug dosage by progressively smaller increments as doses decrease to account for non-linear serotonin transporter receptor occupancy curves.
  • The Flagship “Taper Management” Program: Currently live across 14 U.S. states, the platform combines a specialized network of deprescribing-trained clinicians, individualized evidence-informed tapering schedules, continuous remote symptom tracking, and structured psychosocial support.
  • National Policy Alignment: The funding coincides with federal recognition of deprescribing as a critical care standard. In 2026, the U.S. Department of Health and Human Services (HHS) formally prioritized the development of national evidence-based deprescribing guidelines in collaboration with the American Psychiatric Association (APA) and the American Society of Clinical Psychopharmacology (ASCP).

Capital Allocation & Technical Roadmap

The $7M capital injection will be deployed expanding Outro’s licensed clinical network to grow its footprint beyond the initial 14-state footprint. The expanded pharmacological scope extending its evidence-informed tapering model beyond selective serotonin reuptake inhibitors (SSRIs) and SNRIs into additional psychiatric drug categories prone to physical dependence, including benzodiazepines, sleep aids, and antipsychotics.


“Only a few years ago, it was considered taboo to even talk openly about mental health,” said Brandon Goode, Co-founder and CEO of Outro. “Today, patients are asking a different question: if starting medication deserves support, why does stopping often happen without it? We’ve built the on-ramp for medications. Now it is time to build the off-ramp.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: neurological conditions

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |